Financials
| 2nd Quarter Results | Jul. 30, 2025 |
| 1st Quarter Results | Apr. 30, 2025 |
| GSK plc 2024 Annual Report on Form 20-F | Mar. 03, 2025 |
| GSK publishes Annual Report 2024 | Feb. 27, 2025 |
| 2024 Annual Financial Report | Feb. 27, 2025 |
| Final Results | Feb. 05, 2025 |
| 3rd Quarter Results | Oct. 30, 2024 |
Proxies
| Result of AGM | May. 07, 2025 |
| GSK Proxy Form 2025 | Mar. 24, 2025 |
| GSK AGM Notice 2025 | Mar. 24, 2025 |
| Notice of AGM | Mar. 24, 2025 |
| Result of AGM | May. 08, 2024 |
| GSK Proxy Form 2024 | Mar. 25, 2024 |
| GSK AGM Notice 2024 | Mar. 25, 2024 |
Ownership Update
| Transaction in Own Shares | Sep. 18, 2025 |
| Transaction in Own Shares | Sep. 17, 2025 |
| Transaction in Own Shares | Sep. 16, 2025 |
| Transaction in Own Shares | Sep. 15, 2025 |
| Transaction in Own Shares | Sep. 11, 2025 |
| Director/PDMR Shareholding | Sep. 10, 2025 |
| Transaction in Own Shares | Sep. 10, 2025 |
Announcements
| GSK US Investment Announcement | Sep. 17, 2025 |
| Total Voting Rights | Sep. 01, 2025 |
| FDA to review gonorrhea indication for gepotidacin | Aug. 11, 2025 |
| CureVac/BioNTech mRNA patent litigation settlement | Aug. 08, 2025 |
| Total Voting Rights | Aug. 01, 2025 |
| GSK enters Hengrui Pharma collaboration agreements | Jul. 28, 2025 |
| Blenrep approved in the EU for multiple myeloma | Jul. 24, 2025 |
Prospectuses
| GSK plc;GLAXOSMITHKLINE CAPITAL PLC;GSK Capital B.V.;GSK Capital K.K - Base prospectus (debt) | Sep. 07, 2022 |